Article

Possible involvement of the dopamine D3 receptor locus in subtypes of bipolar affective disorder.

Service de Psychiatrie 2, CHU Timone, Marseille, France.
Psychiatric Genetics (Impact Factor: 2.27). 04/2000; 10(1):43-9. DOI: 10.1097/00041444-200010010-00008
Source: PubMed

ABSTRACT The dopamine D3 receptor gene is of potential interest in the physiopathology of affective disorder because of its expression pattern in brain structures controlling various aspects of behaviour, cognition and emotions. Moreover, it encodes for a receptor protein that is a target for psychotropic drugs, which turn out to be efficient in the treatment of this disorder. Two polymorphisms have been described at this locus (the Bal I and the Msp I Restriction Fragment Length Polymorphisms) that are useful in genetic studies. We therefore researched these polymorphisms in 60 patients suffering from bipolar affective disorder who were compared with 60 healthy volunteers. No statistical difference was observed between the whole patient sample versus the controls. However, one subgroup [homozygous for the (2-2) Bal I polymorphism] exhibits a characteristic clinical pattern consisting of: manic monopolar form of bipolar disorder, low age of onset and initiation by an acute delusional episode. A gender distribution difference for the Bal I polymorphism (chi 2 = 6.61, degrees of freedom = 1, P = 0.01) was then noted, the bipolar females being preferentially heterozygous, and the males homozygous. These results could involve the dopamine D3 receptor locus as a minor effect gene in the manic depression condition.

0 Bookmarks
 · 
76 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Currently available treatments have limited pro-cognitive effects for neuropsychiatric disorders, such as schizophrenia, Parkinson's disease and Alzheimer's disease. The primary objective of this work is to review the literature on the role of dopamine D3 receptors in cognition, and propose dopamine D3 receptor antagonists as possible cognitive enhancers for neuropsychiatric disorders. A literature search was performed to identify animal and human studies on D3 receptors and cognition using PubMed, MEDLINE and EMBASE. The search terms included "dopamine D3 receptor" and "cognition". The literature search identified 164 articles. The results revealed: (1) D3 receptors are associated with cognitive functioning in both healthy individuals and those with neuropsychiatric disorders; (2) D3 receptor blockade appears to enhance while D3 receptor agonism seems to impair cognitive function, including memory, attention, learning, processing speed, social recognition and executive function independent of age; and (3) D3 receptor antagonists may exert their pro-cognitive effect by enhancing the release of acetylcholine in the prefrontal cortex, disinhibiting the activity of dopamine neurons projecting to the nucleus accumbens or prefrontal cortex, or activating CREB signaling in the hippocampus. These findings suggest that D3 receptor blockade may enhance cognitive performance in healthy individuals and treat cognitive dysfunction in individuals with a neuropsychiatric disorder. Clinical trials are needed to confirm these effects.
    European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology 06/2013; DOI:10.1016/j.euroneuro.2013.05.006 · 3.68 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The dopamine system modulates a diverse set of neural functions relevant to neuropsychiatric disorders and is modulated by some drugs used to treat these conditions. As a result, dopamine receptor genes have been a major focus for genetic studies that have analyzed putative associations between polymorphic variants and a wide range of clinical syndromes including alcoholism, substance abuse, schizophrenia, ADHD, anxiety disorders, bipolar and unipolar mood disorders, as well as related traits thought to contribute to these syndromes. In the following chapter, we review the basic genetic organization of the dopamine receptor genes and the evidence for association with these diagnoses. There is considerable inconsistency in the results from these genetic association studies, which is consistent with a complex genetic phenotype, and the neurobiological complexity of behaviors affected in neuropsychiatric illness. Overall, the strongest findings are the associations between variation in the DRD2 gene and alcoholism and the DRD4 gene and ADHD. While these associations do not suggest a major effect on risk in most patients, they do provide important insights into the pathophysiology of these disorders.